Molnupiravir Covid drug reportedly linked to potential virus mutations
Covid19 medicine, Molnupiravir, sold as Lagevrio, has reportedly been linked to specific genetic changes in the virus that causes Covid19, researchers said, raising questions about whether the drug has the potential to accelerate Covid’s evolution. The drug works by creating mutations in the Covid genome to prevent the virus fromRead More →